Junta Nakajima
Junta Nakajima publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations and Hepatocellular Carcinoma Treatment and Prognosis.
- World rank
- #5,985,840 of 7,710,434 ranked researchers
- Rank in Japan
- #221,627 of 383,136
- Works
- 18
- Citations
- 92
- Citations per work
- 5.1
What does Junta Nakajima research?
Junta Nakajima's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1268.6%
- Medicine1268.6%
- Everything else420.3%
- Life Sciences211.1%
- 1Pulmonary and Respiratory Medicine24% of their works
- 2Oncology20% of their works
- 3Surgery13% of their works
- 4Hepatology11% of their works
- 5Molecular Biology7% of their works
- 6Cancer Research4% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Lung Cancer Treatments and Mutations
- Hepatocellular Carcinoma Treatment and Prognosis
- Gastric Cancer Management and Outcomes
- Ubiquitin and proteasome pathways
- Lung Cancer Diagnosis and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Nausea and vomiting management
Which keywords describe Junta Nakajima's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Cetuximab, KRAS Mutations, EGFR Mutations, Targeted Therapy, Adjuvant Therapy and Hepatocellular Carcinoma.
- Ubiquitin
- Postoperative Nausea
- Cholangiocarcinoma
- Biliary Tract Cancer
- Endoscopic Resection
- Hepatocellular Carcinoma
- Targeted Therapy
- KRAS Mutations
- Clinical Practice Guidelines
- Chemotherapy
- Cetuximab
- EGFR Mutations
- Adjuvant Therapy
- Liver Cancer
- Gastric Cancer
- CT Screening
- Lung Cancer
- Proteasome
- Vomiting Prevention
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Chemotherapy123 topics
- Clinical Practice Guidelines82 topics
- Cetuximab71 topic
- KRAS Mutations71 topic
- EGFR Mutations61 topic
- Targeted Therapy61 topic
- Adjuvant Therapy52 topics
- Hepatocellular Carcinoma51 topic
- Liver Cancer51 topic
- Endoscopic Resection31 topic
- Gastric Cancer31 topic
- Biliary Tract Cancer21 topic
- CT Screening21 topic
- Cholangiocarcinoma21 topic
- Lung Cancer21 topic
- Postoperative Nausea21 topic
- Proteasome21 topic
- Ubiquitin21 topic
- Vomiting Prevention21 topic
Where does Junta Nakajima work?
Junta Nakajima's main affiliation in the publication record is Obihiro Kosei General Hospital, Japan.
How many publications and citations does Junta Nakajima have?
OpenAlex counts 18 works and 92 citations for Junta Nakajima, an h-index of 5, ranking #5,985,840 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Junta Nakajima. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.